
Longevity Health
(OTC) XAGE
Longevity Health Financials at a Glance
Market Cap
$646.30K
Revenue (TTM)
$1.79M
Net Income (TTM)
-$6.83M
EPS (TTM)
-$4.31
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.26
Volume
2,614
Open
$0.31
Price
$0.26
Volume
2,614
Open
$0.31
Previous Close
$0.26
Daily Range
$0.26 - $0.31
52-Week Range
$0.23 - $8.27
Estimated Earnings Date
Aug 13, 2025
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.26
Volume
2,614
Open
$0.31
Previous Close
$0.26
Daily Range
$0.26 - $0.31
52-Week Range
$0.23 - $8.27
Estimated Earnings Date
Aug 13, 2025
XAGE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Longevity Health
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Janakiram Ajjarapu, MBA
Website
www.carmellcosmetics.comHeadquarters
Pittsburgh, PA 15203, US
XAGE Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-4%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$646.30K
Shares Outstanding
2.48M
Volume
2.61K
Avg. Volume
2.76K
Financials (TTM)
Gross Profit
$1.09M
Operating Income
-$7.11M
EBITDA
-$6.64M
Operating Cash Flow
-$3.33M
Capital Expenditure
-$14.23K
Free Cash Flow
-$3.34M
Cash & ST Invst.
$706.74K
Total Debt
$499.88K
Longevity Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$391.76K
-23.2%
Gross Profit
$199.71K
-26.0%
Gross Margin
50.98%
N/A
Market Cap
$646.30K
N/A
Market Cap/Employee
$43.09K
N/A
Employees
15
N/A
Net Income
-$1.43M
+4.9%
EBITDA
-$1.49M
-4.3%
Quarterly Fundamentals
Total Cash
$313.40K
-59.3%
Total Debt
$400.62K
-23.2%
Accounts Receivable
$48.67K
-87.7%
Inventory
$734.97K
-46.7%
Long Term Debt
$188.16K
-34.8%
Short Term Debt
$212.45K
-8.8%
Return on Assets
-4.16%
N/A
Return on Invested Capital
1.06%
N/A
Free Cash Flow
-$485.29K
+35.5%
Operating Cash Flow
-$485.29K
+35.5%